跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
human alpha glucosidase
首页
药物
human alpha glucosidase
human alpha glucosidase
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HIGHLY POTENT ACID ALPHA-GLUCOSIDASE WITH ENHANCED CARBOHYDRATES
EP 3201320 B1
申请人: AMICUS THERAPEUTICS INC
优先权: 2014
CN
EP
US
WO
16 件公开
RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE
EP 3624831 B1
申请人: AMICUS THERAPEUTICS INC
优先权: 2017
CN
EP
US
WO
9 件公开
THERAPEUTICS FOR GLYCOGEN STORAGE DISEASE TYPE III
EP 3630964 A4
申请人: ULTRAGENYX PHARMACEUTICAL INC
优先权: 2017
CN
EP
US
WO
7 件公开
TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE GLYCOPROTEIN PROCESSING INHIBITORS
EP 4106752 A2
申请人: UNIV FLORIDA STATE RES FOUND
优先权: 2020
EP
US
WO
7 件公开
Treatment of Pompe's disease
US 7351410 B2
申请人: GENZYME THERAPEUTIC PRODUCTS L
优先权: 2003
US
7 件公开
COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISORDERS
EP 4048286 A4
申请人: AUDENTES THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
4 件公开
THERAPEUTIC ADENO-ASSOCIATED VIRUS COMPRISING LIVER-SPECIFIC PROMOTERS FOR TREATING POMPE DISEASE AND LYSOSOMAL DISORDERS
EP 4061946 A4
申请人: ASKLEPIOS BIOPHARMACEUTICAL INC
优先权: 2019
CN
EP
US
WO
4 件公开
GLYCOENGINEERING OF THERMOTHELOMYCES HETEROTHALLICA
EP 4469590 A4
申请人: DYADIC INT USA INC
优先权: 2022
CN
EP
US
WO
4 件公开
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
US 11060089 B2
申请人: SAREPTA THERAPEUTICS INC
优先权: 2017
US
3 件公开
MODIFIED ACID ALPHA GLUCOSIDASE WITH ACCELERATED PROCESSING
US 2014186326 A1
申请人: CANFIELD WILLIAM
优先权: 2012
CN
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈